REGULATED INFORMATION

FINANCIAL STATEMENTS OF THE GROUP & PARENT COMPANY (IN FRENCH)
FY2017 consolidated accounts – 31 december 2017 Upload
auditors report on fy2017 consolidated accounts – 31 december 2017 Upload
FY2017 annual accounts – 31 december 2017 Upload
auditors report on fy2017 annual accounts – 31 december 2017 Upload
HY2017 Financial report – 30 June 2017 Upload
Statutory auditors report on limited review of HY2017 accounts Upload

 

2016 Management report & analysis Upload
FY2016 consolidated accounts Upload
Statutory auditors report on the FY2016 consolidated accounts Upload
Statutory auditors report on the 2016 regulated agreements Upload
FY2016 statutory accounts of parent company Upload
Statutory auditors report on the FY 2016 accounts of parent company Upload
HY2016 Financial report - 30/06/2016 Upload
Statutory Auditors report on HY2016 accounts as at 30 June Upload

 

2015 Management report & analysis Upload
FY2015 consolidated accounts Upload
Statutory auditors report on the FY2015 consolidated accounts Upload
Statutory auditors report on the 2015 regulated agreements Upload
FY2015 statutory accounts of parent company Upload
FY2015 statutory accounts of parent company Upload
HY2015 Financial report - 30/06/2015 Upload
Statutory auditors report on limited review of HY2015 accounts Upload
2014 Management report & analysis Upload
FY2014 consolidated accounts Upload
Presentation of the 2014 annual results and highlights Upload
Statutory auditors report on the FY2014 consolidated accounts Upload
Statutory auditors report on the 2014 regulated agreements Upload
FY2014 statutory accounts of parent company Upload
FY2014 statutory accounts of parent company Upload
HY2014 consolidated accounts Upload
2013 Management report & analysis Upload
FY2013 consolidated accounts Upload
Statutory auditors report on the FY2013 accounts Upload
Statutory auditors report on the 2013 regulated agreements Upload
HY2013 consolidated accounts Upload
FY2013 statutory accounts of parent company Upload
Satutory auditors report on the FY2013 statutory accounts Upload
2012 Management report & analysis Upload
FY2012 consolidated accounts Upload
Statutory auditors report on FY2012 consolidated accounts Upload
Statutory auditors report on 2012 regulated agreements Upload
HY2012 consolidated accounts Upload
FY2012 statutory accounts of parent company Upload
Statutory auditors report on FY2012 statutory accounts Upload
2011 Management report & analysis Upload
FY2011 consolidated accounts Upload
Statutory auditors report on 2011 regulated agreements Upload
Statutory auditors report on FY2011 consolidated accounts Upload
HY2011 consolidated accounts Upload
FY2011 statutory accounts of parent company Upload
Statutory auditors report on FY2011 statutory accounts Upload
FY2010 consolidated accounts Upload
Statutory auditors report on FY2010 consolidated accounts Upload
HY2010 consolidated accounts Upload
FY2010 statutory accounts of parent company Upload
Statutory auditors report on FY2010 statutory accounts Upload
FY2009 consolidated accounts Upload
Statutuory auditors report on FY2009 consolidated accounts Upload
FY2009 statutory accounts of parent company Upload
Statutory auditors report on FY2009 statutory accounts Upload
DROITS DE VOTE ET ACTIONS
Information concernant le nombre d'actions et de droits de vote (Article L. 233-8 II du Code de commerce, art. 55 de loi)
DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
30 November 2018 265,429,602 273,077,215
31 OCTOBER 2018 254,229,532 261,889,915
30 september 2018 245,428,844 253,068,690
31 august 2018 231,510,121 239,112,084
31 JULY 2018 213,009,946 220,563,205
30 June 2018 202,411,869 209,968,033
31 May 2018 199,810,892 207,341,307
30 April 2018 183,908,788 192,123,096
31 MArCH 2018 179,255,357 187,293,012
28 FEBRuary 2018 166,206,577 174,251,173
31 january 2018 152,970,026 161,486,914

Tracking the number of shares outstanding

This chart (in French) tracks the number of outstanding shares in connection with the financing through issuance and subscritption of warrants giving access to convertible notes into new shares (BEOCA) as described in the press release of 09/02/2018.

See the chart of shares oustanding in connection with BEOCA

Tracking the number of shares outstanding

This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) as described in the press release of 21/07/2016.

See the chart of shares oustanding in connection with OCABSA

DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
31 DECEMber 2017 152,537,636 160,451,671
30 noVEMber 2017 152,519,078 160,444,792
31 october 2017 152,405,521 160,331,705
30 september 2017 152,392,759 160,283,325
31 August 2017 146,963,399 154,858,986
31 July 2017 143,862,922 151,943,073
30 June 2017 139,981,055 148,065,084
31 may 2017 131,077,601 138,980,348
30 April 2017 127,158,554 135,044,557
31 March 2017 127,158,554 135,045,233
28 February 2017 116,415,854 124,267,670
31 January 2017 116,415,854 124,274,214

Tracking the number of shares outstanding

This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) as described in the press release of 21/07/2016.

See the chart of shares oustanding in connection with OCABSA

DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
31 december 2016 111,653,949 119,295,164
30 november 2016 98,798,391 107,641,956
31 october 2016 88,797,840 96,166,029
30 september 2016 83,616,988 90,984,287
31 August 2016 77,075,383 84,636,943
31 July 2016 73,122,269 80,516,074
30 June 2016 72,535,421** 80,659,913
31 may 2016 70,535,400* 78,069,140
30 April 2016 69,667,524 76,449,043
31 March 2016 69,667,524 76,451,564
29 February 2016 69,667,524 76,407,791
31 January 2016 69,667,524 76,072,316

* 750,000 shares issued as part of the Equity Line

** 2,000,000 shares issued as part of the Equity Line See the press release of 25/02/2016

As part of the Equity Line contract, 2,750,000 shares in total have been issued for a gross amount of €1,405,00 i.e. an average price of €0.51/share.

Tracking the number of shares outstanding

This chart (in French) tracks the number of outstanding shares in connection with the flexible bond financing (OCABSA) as described in the press release of 21/07/2016.

See the chart of shares oustanding in connection with OCABSA

DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
31 December 2015 69,667,524 75,867,882
30 November 2015 69,427,212 76,173,317
31 October 2015 69,427,212 76,173,426
12 October 2015 69,427,212 76,166,843
30 September 2015 69,370,051 76,109,682
31 August 2015 69,370,051 76,110,821
31 July 2015 69,370,051 76,114,698
16 July 2015 69,370,051 76,119,863
30 June 2015 69,274,211 76,024,023
31 May 2015 69,274,211 75,929,499
18 May 2015 69,274,211 75,928,450
13 May 2015 69,274,211 75,961,449
30 April 2015 69,274,211 75,932,490
31 March 2015 69,044,970 75,702,722
28 February 2015 69,044,970 75,720,253
31 January 2015 69,044,970 75,727,162

Declaration of transaction on shares - François MARCHAL, Director of the Group.
See the declaration

DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
31 December 2014 69,044,970* 75,731,526
30 November 2014 68,027,795 74,716,295
4 November 2014 68,027,795 74,737,362
30 September 2014 23,137,013 29,933,953
31 August 2014 23,137,013 30,105,388
31 July 2014 23,092,013 30,060,388
30 June 2014 23,092,013 30,072,276
31 May 2014 23,032,513 30,013,426
30 April 2014 23,032,513 30,011,204
31 March 2014 23,032,513 30,011,204
28 February 2014 23,032,513 30,258,790
31 January 2014 23,032,513 30,620,691

* Between November and December 2014 the capital increase is due to the subscription of BSAR A and B which resulted the issuing of 1,017,175 new shares.

NB : On 06/11/2014 the company issued 68,027,795 BSAR A and BSAR B. The new shares resulting formm the exercise of BSAR A and BSAR B will be subject to periodic requests for admission to trading on Alternext Euronext Paris and will be listed under the same ISIN code as existing shares, i.e. FR0000044810.

Declaration of transaction on shares:Credit Suisse Europlasma SPV LLC
See the declaration

Declaration of threshold crossing: Credit Suisse Europlasma SPV LLC
See the declaration

Declaration of transaction on shares: Erik MARTEL (legal representative of Masdar Venture Capital), Director of the Group
See the declaration

Declaration of transaction on shares: Jean-Eric PETIT, CEO of the Group
See the declaration

Declaration of transaction on shares: François MARCHAL, Director of the Group
See the declaration

Declaration of transaction on shares: Pierre CATLIN, Chairman of the Group
See the declaration

Declaration of transaction on shares: Credit Suisse Europlasma SPV LLC
See the declaration

Declaration of threshold crossing: Credit Suisse Europlasma SPV LLC
See the declaration

Declaration of transaction on shares: François Marchal, Director of the Group
See the declaration

Declaration of transaction on shares: François Marchal, Director of the Group
See the declaration

Declaration of transaction on shares: Credit Suisse Europlasma SPV LLC
See the declaration

Declaration of threshold crossing: Credit Suisse Europlasma SPV LLC
See the declaration

Declaration of transaction on shares: Jean-Eric PETIT, CEO of the Group
See the declaration

DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
31 December 2013 15,764,735 23,430,943
30 november 2013 15,764,735 23,520,550
08 november 2013 15,764,735 23,754,831
30 september 2013 15,764,735 24,005,254
31 August 2013 15,737,235 23,977,977
31 July 2013 15,737,235 23,976,857
30 June 2013 15,737,235 23,973,851
31 May 2013 15,737,235 23,963,177
30 April 2013 15,737,235 24,085,177
31 March 2013 15,737,235 24,025,692
28 February 2013 15,737,235 24,098,447
31 January 2013 15,737,235 24,264,025

The share capital comprises 15 764 735 common shares.

The above information is updated if it changes compared to the previous publication.

DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
31 December 2012 15,737,235 24,330,320
30 November 2012 15,737,235 24,070,750
31 October 2012 15,737,235 24,088,360
30 September 2012 15,737,235 24,151,078
31 August 2012 15,737,235 21,999,133
31 July 2012 15,737,235 21,813,948
20 June 2012 15,737,235 21,601,353
31 may 2012 15,737,235 21,599,526
30 April 2012 15,656,035 21,466,311
31 March 2012 15,656,035 21,462,731
29 February 2012 15,656,035 21,436,549
31 January 2012 15,656,035 21,412,731

The share capital is composed of 13 532 235 common shares (listed) and 2 205 000 preferred shares (non listed).

The above information is updated if it changes compared to the previous publication.

Information document on warrants expiration December 23rd, 2010

Declarations of transaction on shares

Crossing of the Threshold - June 28th 2012 Read the press release

DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
31 December 2011 15,656,035 21,250,321
30 November 2011 15,656,035 21,256,478
31 October 2011 15,656,035 21,242,828
30 September 2011 15,656,035 21,052,184
31 August 2011 15,656,035 20,873,824
31 July 2011 15,656,035 20,868,538
30 June 2011 15,656,035 20,819,799
21 June2011 15,656,035 20,777,366
31 may 2011 15,656,035 20,838,107
30 April 2011 15,656,035 20,472,378
31 March 2011 15,285,047 20,469,758
28 February 2011 15,285,047 22,750,668
31 January 2011 15,285,047 20,585,451

Declarations of transactions on shares

Declaration of Didier Pineau, Europlasma's Managing Director - 21/12/2011 - Read the document

Declaration of Didier Pineau, Europlasma's Managing Director - 12/12/2011 - Read the document

DATE OUSTANDING SHARES NUMBER OF THEORICAL VOTING RIGHTS
21 October 2010 15,285,047 22,150,197
30 June 2010 11,511,752 19,076,958

Declarations of transactions on shares

Declaration of Didier Pineau, Europlasma's Managing Director - 12/10/2010 - Read the document

Declaration of 15/09/2010 - Read the document

Declaration of 01/09/2010 - Read the document

Declaration of 18/08/2010 - Read the document

MONTHLY DECLARATION OF TRADING IN OWN SHARES UNDER THE LIQUIDITY CONTRACT
Nature of securities : share Share capital owned directly at the date of publication of the program : 0/0

Begining of the program 05/03/2012

Balance as at 31/10/2018 : 329,369
Number of shares purchased : 51,001
Number of shares sold : 160,370

Begining of the program 05/03/2012

Balance as at 30/09/2018 : 255,369
Number of shares purchased : 89,002
Number of shares sold : 15,002

Begining of the program 05/03/2012

Balance as at 31/08/2018 : 302,819
Number of shares purchased : 58,000
Number of shares sold : 105,450

Begining of the program 05/03/2012

Balance as at 31/07/2018 : 294,819
Number of shares purchased : 53,005
Number of shares sold : 45,005

Begining of the program 05/03/2012

Balance as at 30/06/2018 : 249,819
Number of shares purchased : 50,000
Number of shares sold : 5,000

Begining of the program 05/03/2012

Balance as at 30/05/2018 : 263,819
Number of shares purchased : 66,002
Number of shares sold : 80,002

Begining of the program 05/03/2012

Balance as at 30/04/2018 : 251,819
Number of shares purchased : 61,001
Number of shares sold : 49,001

Begining of the program 05/03/2012

Balance as at 31/03/2018 : 156,819
Number of shares purchased : 110,003
Number of shares sold : 15,003

Begining of the program 05/03/2012

Balance as at 28/02/2018 : 201,819
Number of shares purchased : 70,001
Number of shares sold : 115,001

Begining of the program 05/03/2012

Balance as at 31/01/2018 : 211,819
Number of shares purchased : 65,000
Number of shares sold : 75,000

Begining of the program 05/03/2012

Balance as at 31/12/2017 : 200,819
Number of shares purchased : 43,002
Number of shares sold : 32,000

Begining of the program 05/03/2012

Balance as at 30/11/2017 : 232,819
Number of shares purchased : 18,000
Number of shares sold : 50,000

Begining of the program 05/03/2012

Balance as at 31/10/2017 : 221,819
Number of shares purchased : 16,000
Number of shares sold : 5,000

Begining of the program 05/03/2012

Balance as at 30/09/2017 : 235,819
Number of shares purchased : 11,000
Number of shares sold : 25,000

Begining of the program 05/03/2012

Balance as at 31/08/2017 : 231,219
Number of shares purchased : 19,601
Number of shares sold : 15,001

Begining of the program 05/03/2012

Balance as at 31/07/2017 : 198,119
Number of shares purchased : 43,100
Number of shares sold : 10,000

Begining of the program 05/03/2012

Balance as at 30/06/2017 : 182,119
Number of shares purchased : 16,002
Number of shares sold : 2

Begining of the program 05/03/2012

Balance as at 31/05/2017 : 218,205
Number of shares purchased : 51,001
Number of shares sold : 87,087

Begining of the program 05/03/2012

Balance as at 30/04/2017 : 151,005
Number of shares purchased : 84,202
Number of shares sold : 17,002

Begining of the program 05/03/2012

Balance as at 31/03/2016 : 133,127
Number of shares purchased : 44,707
Number of shares sold : 31,578

Begining of the program 05/03/2012

Balance as at 31/03/2017 : 198,005
Number of shares purchased : 55,000
Number of shares sold : 102,000

Begining of the program 05/03/2012

Balance as at 29/02/2016 : 131,127
Number of shares purchased : 57,008
Number of shares sold : 55,008

Begining of the program 05/03/2012

Balance as at 28/02/2017 : 79,940
Number of shares purchased : 155,000
Number of shares sold : 31,935

Begining of the program 05/03/2012

Balance as at 31/01/2017 : 232,825
Number of shares purchased : 35,001
Number of shares sold : 192,886

Begining of the program 05/03/2012

Balance as at 31/12/2016 : 216,025
Number of shares purchased : 106,800
Number of shares sold : 90,000

Begining of the program 05/03/2012

Balance as at 30/11/2016 : 186,025
Number of shares purchased : 90,000
Number of shares sold : 60,000

Begining of the program 05/03/2012

Balance as at 31/10/2016 : 192,970
Number of shares purchased : 125,003
Number of shares sold : 131,948

Begining of the program 05/03/2012

Balance as at 30/09/2016 : 197,970
Number of shares purchased : 75,000
Number of shares sold : 80,000

Begining of the program 05/03/2012

Balance as at 31/08/2016 : 111,205
Number of shares purchased : 115,003
Number of shares sold : 28,238

Begining of the program 05/03/2012

Balance as at 31/07/2016 : 124,205
Number of shares purchased : 72,005
Number of shares sold : 85,005

Begining of the program 05/03/2012

Balance as at 30/06/2016 : 141,014
Number of shares purchased : 118,703
Number of shares sold : 135,512

Begining of the program 05/03/2012

Balance as at 31/05/2016 : 171,305
Number of shares purchased : 55,505
Number of shares sold : 85,796

Begining of the program 05/03/2012

Balance as at 30/04/2016 : 146,256
Number of shares purchased : 47,060
Number of shares sold : 22,011

Begining of the program 05/03/2012

Balance as at 31/01/2016 : 167,227
Number of shares purchased : 53,904
Number of shares sold : 90,004

Begining of the program 05/03/2012

Balance as at 31/12/2015 : 135,227
Number of shares purchased : 47,001
Number of shares sold : 15,001

Begining of the program 05/03/2012

Balance as at 30/11/2015 : 130,227
Number of shares purchased : 115,001
Number of shares sold : 110,001

Begining of the program 05/03/2012

Balance as at 31/10/2015 : 120,753
Number of shares purchased : 108,669
Number of shares sold : 99,195

Begining of the program 05/03/2012

Balance as at 30/09/2015 : 91,803
Number of shares purchased : 116,005
Number of shares sold : 87,055

Begining of the program 05/03/2012

Balance as at 31/08/2015 : 128,858
Number of shares purchased : 87,010
Number of shares sold : 124,065

Begining of the program 05/03/2012

Balance as at 31/07/2015 : 98,141
Number of shares purchased : 71,506
Number of shares sold : 40,789

Begining of the program 05/03/2012

Balance as at 30/06/2015 : 105,566
Number of shares purchased : 26,579
Number of shares sold : 34,004

Begining of the program 05/03/2012

Balance as at 31/05/2015 : 41,366
Number of shares purchased : 135,002
Number of shares sold : 70,802

Begining of the program 05/03/2012

Balance as at 30/04/2015 : 89,926
Number of shares purchased : 35,443
Number of shares sold : 84,003

Begining of the program 05/03/2012

Balance as at 31/03/2015 : 103,207
Number of shares purchased : 80,000
Number of shares sold : 93,281

Begining of the program 05/03/2012

Balance as at 28/02/2015 : 69,423
Number of shares purchased : 151,252
Number of shares sold : 117,468

Begining of the program 05/03/2012

Balance as at 31/01/2015 : 58,695
Number of shares purchased : 149,000
Number of shares sold : 138,272

Begining of the program 05/03/2012

Balance as at 31/12/2014 : 102,620
Number of shares purchased : 186,076
Number of shares sold : 230,001

Begining of the program 05/03/2012

Balance as at 31/11/2013 : 22,038
Number of shares purchased : 258,555
Number of shares sold : 224,305

Begining of the program 05/03/2012

Balance as at 30/11/2014 : 46,270
Number of shares purchased : 158,850
Number of shares sold : 102,500

Begining of the program 05/03/2012

Balance as at 31/10/2014 : 109,270
Number of shares purchased : 165,000
Number of shares sold : 228,000

Begining of the program 05/03/2012

Balance as at 30/09/2014 : 41,513
Number of shares purchased : 101,757
Number of shares sold : 34,000

Begining of the program 05/03/2012

Balance as at 31/08/2014 : 40,813
Number of shares purchased : 52,501
Number of shares sold : 51,801

Begining of the program 05/03/2012

Balance as at 31/07/2014 : 40,813
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 30/06/2014 : 40,813
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 31/05/2014 : 40,813
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 30/04/2014 : 40,813
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 31/03/2014 : 40,813
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 28/02/2014 : 10,046
Number of shares purchased : 238,316
Number of shares sold : 207,549

Begining of the program 05/03/2012

Balance as at 31/01/2014 : 40,346
Number of shares purchased : 225,700
Number of shares sold : 256,000

Begining of the program 05/03/2012

Balance as at 31/12/2013 : 56,288
Number of shares purchased : 184,004
Number of shares sold : 199,946

Begining of the program 05/03/2012

Balance as at 31/10/2013 : 90,204
Number of shares purchased : 78,686
Number of shares sold : 146,852

Begining of the program 05/03/2012

Balance as at 30/09/2013 : 102,886
Number of shares purchased : 85,834
Number of shares sold : 98,516

Begining of the program 05/03/2012

Balance as at 31/08/2013 : 92,218
Number of shares purchased : 13,668
Number of shares sold : 3,000

Begining of the program 05/03/2012

Balance as at 31/07/2013 : 92,218
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 30/06/2013 : 92,218
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 31/05/2013 : 92,218
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 30/04/2013 : 92,218
Number of shares purchased : 0
Number of shares sold : 0

Begining of the program 05/03/2012

Balance as at 31/03/2013 : 85,245
Number of shares purchased : 15,487
Number of shares sold : 8,514

Begining of the program 05/03/2012

Balance as at 28/02/2013 : 68,829
Number of shares purchased : 49,710
Number of shares sold : 33,294

Begining of the program 05/03/2012

Balance as at 31/01/2013 : 59,874
Number of shares purchased : 61,613
Number of shares sold : 52,658

Begining of the program 05/03/2012

Balance as at 31/12/2012 : 56,909
Number of shares purchased : 48,687
Number of shares sold : 45,722

Begining of the program 05/03/2012

Balance as at 30/11/2012 : 77,080
Number of shares purchased : 30,698
Number of shares sold : 50,869

Begining of the program 05/03/2012

Balance as at 31/10/2012 : 76,245
Number of shares purchased : 41,777
Number of shares sold : 40,942

Begining of the program 05/03/2012

Balance as at 30/09/2012 : 69,330
Number of shares purchased : 53,788
Number of shares sold : 46,873

Begining of the program 05/03/2012

Balance as at 31/08/2012 : 63,775
Number of shares purchased : 22,803
Number of shares sold : 17,248

Begining of the program 05/03/2012

Balance as at 31/07/2012 : 68,861
Number of shares purchased : 16,956
Number of shares sold : 22,042

Begining of the program 05/03/2012

Balance as at 30/06/2012 : 58,803
Number of shares purchased : 34,912
Number of shares sold : 24,854

Begining of the program 05/03/2012

Balance as at 31/05/2012 : 68,861
Number of shares purchased : 14,169
Number of shares sold : 24,227

Begining of the program 05/03/2012

Balance as at 30/04/2012 : 75,199
Number of shares purchased : 25,539
Number of shares sold : 31,877

Begining of the program 05/03/2012

Balance as at 31/03/2012 : 85,049
Number of shares purchased : 56,362
Number of shares sold : 66,212

Begining of the program 05/03/2012

Balance as at 29/02/2012 : 51,184
Number of shares purchased : 90,895
Number of shares sold : 57,030

Begining of the program 05/03/2012

Balance as at 31/01/2012 : 47,507
Number of shares purchased : 43,989
Number of shares sold : 40,312

Begining of the program 30/06/2009

Balance as at 31/12/2011 : 65,913
Number of shares purchased : 39,992
Number of shares sold : 58,398

Begining of the program 30/06/2009

Balance as at 30/11/2011 : 67,135
Number of shares purchased : 36,805
Number of shares sold : 44,177

Begining of the program 30/06/2009

Balance as at 31/10/2011 : 65,830
Number of shares purchased : 48,903
Number of shares sold : 45,688

Begining of the program 30/06/2009

Balance as at 30/09/2011 : 67,050
Number of shares purchased : 12,646
Number of shares sold : 13,876

Begining of the program 30/06/2009

Balance as at 31/08/2011 : 65,119
Number of shares purchased : 31,263
Number of shares sold : 29,332

Begining of the program 30/06/2009

Balance as at 29/07/2011 : 64,745
Number of shares purchased : 34,395
Number of shares sold : 34,021

Begining of the program 30/06/2009

Balance as at 30/06/2011 : 77,674
Number of shares purchased : 22,628
Number of shares sold : 35,557

Begining of the program 30/06/2009

Balance as at 31/05/2011 : 66,845
Number of shares purchased : 60,683
Number of shares sold : 49,853

Begining of the program 30/06/2009

Balance as at 30/04/2011 : 66,496
Number of shares purchased : 40,860
Number of shares sold : 42,445

Begining of the program 30/06/2009

Balance as at 31/03/2011 : 62,711
Number of shares purchased : 86,548
Number of shares sold : 82,763

Begining of the program 30/06/2009

Balance as at 28/02/2011 : 62,879
Number of shares purchased : 71,638
Number of shares sold : 71,806

Begining of the program 30/06/2009

Balance as at 31/01/2011 : 54,153
Number of shares purchased : 38,550
Number of shares sold : 29,825

Begining of the program 30/06/2009

Balance as at 31/12/2010 : 152,905
Number of shares purchased : 3,890
Number of shares sold : 6,8998

FINANCIAL PRESS RELEASE

07/12/2018

Update on funding prospects

05/12/2018

Number of shares and voting rights as at 30/11/2018

12/11/2018

Europlasma announces the suspension of the exercise of the 4th warrant given access to convertible bonds.

06/11/2018

Information relative to the number of shares and voting rights as at 31/10/2018

31/10/2018

Half-year consolidated Results as at 30/06/2018

12/10/2018

Reactivation of the financing agreement by issuance of convertible bonds

04/10/2018

Number of shares and voting rights as at 30/09/2018

27/09/2018

General Meeting of Shareholders on 27 September 2018

05/09/2018

Europlasma announces the signature of a partnership framework agreement with Orano Cycle and the progression of discussions with financial investors to have a reference sharholder

04/09/2018

Information relative to number of shares and voting rights as at 31/08/2018

03/09/2018

Europlasma announces the suspension of the exercise of the 3rd warrant given access to convertible bonds.

08/08/2018

Information relative to number of shares and voting rights as at 31st July.

26/07/2018

Update on the commercial activity of the Group

17/07/2018

Renewal of the convertible bond financing agreement

05/07/2018

Information relative to number of shares and voting rights as at 30 June.

04/07/2018

Half-year report on liquidity contract as at 30/06/2018

28/06/2018

Annual General Meeting, new call on 27 September 2018

21/06/2018

Annual General Meeting, new call

21/06/2018

Update on the Group's activity

07/06/2018

Information relative to number of shares and voting rights as at 31 May.

14/05/2018

Information relative to number of shares and voting rights as at 30 April.

27/04/2018

Filing of the 2017 Registration Document ("Document de Référence 2017")

17/04/2018

2017 Annual Results of the Group

13/04/2018

Europlasma announces an agreement with European High Growth Opportunities Securitization Fund improving the conditions of the 3rd tranche of convertible bonds

05/04/2018

Information relative to number of shares and voting rights as at 31 March.

28/03/2018

EIB and Europlasma announce the signature of a € 30 million financing contract for the innovative CHO Tiper project

22/03/2018

Europlasma announces a capital increase in its subsidiary CHO Power, valuing it at €101 million, and a simultaneous reorganisation of CHO Morcenx

05/03/2018

Number of shares and voting rights as at 28/02/2018

26/02/2018

Europlasma commits alongside Arcelor Mittal to reducing the carbon footprint of the steel industry

09/02/2018

Convertible bonds financing contract for a maximum amount of EUR 8 million

06/02/2018

Number of shares and voting rights as at 31/01/2018

10/01/2018

Half-year report on liquidity contract

04/01/2018

Number of shares and voting rights as at 31/12/2017

20/12/2017

BEI announces its intention to support the CHO Tiper project by providing up to 30 million euro

05/12/2017

Number of shares and voting rights as at 30/11/2017

14/11/2017

Information relative to BSAR C

07/11/2017

Number of shares and voting rights as at 31/10/2017

26/10/2017

General Meeting of Shareholders of 26/10/2017

24/10/2017

Half-year results as at 30 June 2017

10/10/2017

General Meeting of Shareholders, new call

10/10/2017

Number of shares and voting rights as at 30/09/2017

26/09/2017

Review of the 2014-2017 Strategy and Growth Perspective

11/09/2017

Number of shares and voting rights as at 31/08/2017

06/09/2017

Delivery of the plasma facility for the treatment of low-level radioactive waste in Bulgaria

23/08/2017

Debt reduction: capital increase by conversion of debts

03/08/2017

Number of shares and voting rights as at 31/07/2017

26/07/2017

Issuance of the last tranche of OCABSA

24/07/2017

Delivery of the vitrification unit for fly ash in China

05/07/2017

Half-year report on liquidity contract

04/07/2017

Number of shares and voting rights as at 30/06/2017

03/07/2017

Issuance of OCABSA Tranche 13

29/06/2017

General Meeting of Shareholders of 29 June 2017

15/06/2017

General Meeting of Shareholders, new call

14/06/2017

Europlasma announces Final Acceptance of the CHO Morcenx plant

13/06/2017

Issuance of OCABSA Tranche 12

07/06/2017

Number of shares and voting rights as at 31/05/2017

06/06/2017

Renewal eligibility for the French PEA-PME regime

30/05/2017

Issuance of OCABSA Tranche 11

15/05/2017

Issuance of OCABSA Tranche 10

05/05/2017

Number of shares and voting rights as at 30/04/2017

28/04/2017

Availability of the 2016 Registration Document

19/04/2017

Europlasma announces its results for the year ended December 31, 2016

10/04/2017

CHO Morcenx power plant: acceptance of the second GE Jenbacher engine

04/04/2017

Number of shares and voting rights as at 31/03/2017

21/03/2017

CHO Morcenx power plant: update on the acceptance of the second GE Jenbacher engine

08/03/2017

Number of shares and voting rights as at 28/02/2017

20/02/2017

CHO Morcenx power plant: acceptance of the first Jenbacher engine successfully performed

09/02/2017

Number of shares and voting rights as at 31/01/2017

23/01/2017

Issuance of OCABSA Tranche 9 / CHO Morcenx power plant update

06/01/2017

HY report on the liquidity contract

22/12/2016

Corporate events

19/12/2016

Update on the different business units

15/12/2016

Issuance of OCABSA Tranche 7

07/11/2016

Nuclear Industry calls on Europlasma once again

26/10/2016

Half-year 2016 Results

31/08/2016

Delivery of the additional engines at CHO Morcenx plant, resumption of production at Inertam, return of Erik Martel within the Board of Directors

21/07/2016

Changes in governance and financing structure

21/07/2016

Activity review

13/07/2016

12M€ support from ADEME

05/07/2016

Half-year report on Europlasma liquidity contract

30/06/2016

Renewal eligibility for the French PEA-PME regime

28/04/2016

Filing of the 2015 Registration Document

21/04/2016

2015 annual results and highlights

20/04/2016

Appointment of Yann Le Doré as independent Director

25/02/2016

2015 Turnover, update on cash position and implementation of equity line financing

25/02/2016

2015 Turnover, update on cash position and implementation of equity line financing

25/01/2016

Order of the additional engines for the CHO Morcenx power plant

07/01/2016

Half-year report as at 31/12/2015 on the liquidity contract

11/12/2015

Private Placement of EUR 5 million

30/11/2015

CHO Power: FAR secured at Morcenx

30/10/2015

Consolidated results at 30 June 2015

09/09/2015

CHO Morcenx: FAR protocol to resume in September

29/07/2015

Renewal of the eligibility for the French PEA-PME regime

27/07/2015

CHO Morcenx: update on "Final Acceptance with Reserves"

02/07/2015

Half-year report as at 30/06/2015 on the liquidity contract

02/06/2015

Filing of the 2014 Registration Document

30/04/2015

2014 Annual Results

23/01/2015

Capital increase by BSAR subscription

16/01/2015

Half-year report as at 31/12/2014 on liquidity contract

17/12/2014

CHO Morcenx status update

31/10/2014

Success of the capital increase: €35.9 million

31/10/2014

2014 Half-Year consolidated results

15/10/2014

Technical and commercial progress update of CHO Power

24/09/2014

Launch of a capital increase (abstract)

08/09/2014

Resumption of trading on September 9, 2014

04/09/2014

Minute of the AGM of 01/09/2014

22/08/2014

2013 Annual Consolidated Results

20/08/2014

Half year report of the liquidty contract as at 30/06/2014

01/08/2014

Eligibility to PEA-PME

25/07/2014

Annual Shareholders Meeting of 1st September, 2014

03/07/2014

Update on the Group's financial position - Change in Board composition

24/06/2014

Preliminary Take Over of the CHO Morcenx power plant - Trading suspension maintained

29/04/2014

FY2013 Accounts publication delayed

08/04/2014

Clarification on stock trading suspension

10/03/2014

Update on the commissioning of the CHO Morcenx power plant

27/02/2014

Update on the commissioning of the CHO Morcenx power plant

31/01/2014

Success of the Reserved Capital Increase

27/01/2014

BALO notice – Erratum

17/01/2014

Capital Increase: extension of the subscription period

10/01/2014

Half-year report of the liquidity contract

03/01/2014

BALO notice - Capital increase

03/01/2014

New Capital Increase

17/12/2013

Completion of the sale of the Air & Gas sector

21/11/2013

Sale of the Air and Gas sector

31/10/2013

Consolidated results as at 30 June 2013

09/10/2013

Modification of the liquidity contract

26/09/2013

Resumption of trading, New funding provided

26/09/2013

FY2012 Consolidated Results

11/07/2013

Group's business and organisation update

05/07/2013

Half-year report of the liquidity contract

15/04/2013

Suspension of trading

07/01/2013

Half-year report of the liquidity contract

18/12/2012

Agreement signed for 8 future CHO Power plants

30/10/2012

Consolidated results as at 30 June 2012

03/07/2012

Half-year report of the liquidity contract

28/06/2012

Crossing of the threshold

21/06/2012

Celebration of the CHO Power plant construction completion

30/05/2012

Filing of French "Document de Référence 2011"

26/03/2012

FY2011 consolidated results

05/03/2012

Discontinuation and establishment of a liquidity agreement

06/01/2012

Half-year report of the liquidity contract

06/10/2011

HY2011 consolidated results

08/09/2011

First semester report of the liquidity provider contract

08/09/2011

Release of the "Document de référence" 2010

28/04/2011

2010 Year-end results

14/04/2011

Strong growth 2010 confirmed

26/01/2011

Discontinuation and establishment of a liquidity agreement

13/01/2011

Biannual liquidity contract contracted with Oddo Corporate Finance

02/12/2010

Breaking ground of CHO Morcenx power plant

28/10/2010

2010 First-half earnings

08/09/2010

Europe Environnement wins a €10m contract

25/08/2010

Success of the two capital increases

30/07/2010

Reserved capital increase prolongation

12/07/2010

Europlasma launches a capital increase

05/07/2010

First semester report of the liquidity provider contract

23/06/2010

Report on the Combined General Meeting on 30 June 2010

14/06/2010

Additional information concerning the financial impact of the CHO Power plants development

30/04/2010

2009 full-year earnings

08/04/2010

New letter of intent signed for financing CHO Power units